Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<div class="info-card warning">
<p><strong>For subcutaneous use after reconstitution.</strong> Dragontropin (Somatropin) is a recombinant human growth hormone supplied as a lyophilized powder. It must be reconstituted with <a href="/peptides-414/bacteriostatic-water-48726">bacteriostatic water</a> prior to administration.</p>
</div>
<h3>Administration Profile</h3>
<ul class="usage-highlights">
<li>✔ Lyophilized peptide requiring reconstitution</li>
<li>✔ Subcutaneous injection (preferred method)</li>
<li>✔ Typically administered daily or split into multiple doses</li>
</ul>
<p>After reconstitution, Dragontropin is commonly administered via subcutaneous injection. Injection sites should be rotated to minimize irritation and ensure consistent absorption.</p>
<h3>Typical Use Context</h3>
<ul>
<li><strong>General wellness / anti-aging context:</strong> 1–2 IU daily</li>
<li><strong>Performance-focused use:</strong> 2–4 IU daily</li>
<li><strong>Advanced protocols:</strong> 4–6 IU daily (often split AM + PM)</li>
</ul>
<p>Growth hormone protocols are typically structured over longer periods compared to anabolic compounds, with consistent daily administration used to support gradual physiological effects.</p>
<h3>Stacking Context</h3>
<p>Dragontropin is often used alongside structured training, nutrition, and recovery protocols. In performance settings, it may be combined with other compounds depending on individual goals.</p>
<h3>Side Effects and Safety</h3>
<ul>
<li>Water retention (dose-dependent)</li>
<li>Tingling or numbness in extremities</li>
<li>Temporary joint stiffness</li>
<li>Possible insulin sensitivity changes at higher doses</li>
</ul>
<p>Most side effects are dose-related and can be managed by adjusting administration protocols.</p>
<h3>Post-Use Considerations</h3>
<p>Post-cycle therapy (PCT) is not required when using Dragontropin alone, as it does not suppress endogenous testosterone production. If used alongside suppressive compounds, follow appropriate recovery protocols.</p>
<div class="info-card">
<p><strong>Important:</strong> Individual response varies. Dosing strategies and protocols should be adjusted based on experience level and, where possible, supported by bloodwork.</p>
</div>
</section>
</div>
Product Details
Active Substance
Somatropin (recombinant human growth hormone)
Formulation
Lyophilized Powder
Kit Size
100 IU total (10 × 10 IU vials)
Verified Assay
4.67 mg (≈14.01 IU)
~140.14% of label claim · Batch #Unknown
Administration
Subcutaneous (after reconstitution)
Availability
USA Domestic & International